Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Changing from lipoprotein apheresis to evolocumab treatment lowers circulating levels of arachidonic acid and oxylipins.
Wang C, Kaufmann A, Kampschulte N, Elbelt U, Kassner U, Steinhagen-Thiessen E, Pietzner A, Schmöcker C, Datta D, Sanpietro T, Schebb NH, Weylandt KH, Rohwer N. Wang C, et al. Among authors: rohwer n. Atheroscler Plus. 2024 Feb 12;55:55-62. doi: 10.1016/j.athplu.2024.01.005. eCollection 2024 Mar. Atheroscler Plus. 2024. PMID: 38390468 Free PMC article.
Modulation of the endogenous omega-3 fatty acid and oxylipin profile in vivo-A comparison of the fat-1 transgenic mouse with C57BL/6 wildtype mice on an omega-3 fatty acid enriched diet.
Ostermann AI, Waindok P, Schmidt MJ, Chiu CY, Smyl C, Rohwer N, Weylandt KH, Schebb NH. Ostermann AI, et al. Among authors: rohwer n. PLoS One. 2017 Sep 8;12(9):e0184470. doi: 10.1371/journal.pone.0184470. eCollection 2017. PLoS One. 2017. PMID: 28886129 Free PMC article.
Sorafenib increases cytochrome P450 lipid metabolites in patient with hepatocellular carcinoma.
Leineweber CG, Rabehl M, Pietzner A, Rohwer N, Rothe M, Pech M, Sangro B, Sharma R, Verslype C, Basu B, Sengel C, Ricke J, Schebb NH, Weylandt KH, Benckert J. Leineweber CG, et al. Among authors: rohwer n. Front Pharmacol. 2023 Mar 3;14:1124214. doi: 10.3389/fphar.2023.1124214. eCollection 2023. Front Pharmacol. 2023. PMID: 36937889 Free PMC article.
Corrigendum: Sorafenib increases cytochrome P450 lipid metabolites in patient with hepatocellular carcinoma.
Leineweber CG, Rabehl M, Pietzner A, Rohwer N, Rothe M, Pech M, Sangro B, Sharma R, Verslype C, Basu B, Sengel C, Ricke J, Schebb NH, Weylandt KH, Benckert J. Leineweber CG, et al. Among authors: rohwer n. Front Pharmacol. 2024 Jan 11;14:1354581. doi: 10.3389/fphar.2023.1354581. eCollection 2023. Front Pharmacol. 2024. PMID: 38273836 Free PMC article.
Formation, Signaling and Occurrence of Specialized Pro-Resolving Lipid Mediators-What is the Evidence so far?
Schebb NH, Kühn H, Kahnt AS, Rund KM, O'Donnell VB, Flamand N, Peters-Golden M, Jakobsson PJ, Weylandt KH, Rohwer N, Murphy RC, Geisslinger G, FitzGerald GA, Hanson J, Dahlgren C, Alnouri MW, Offermanns S, Steinhilber D. Schebb NH, et al. Among authors: rohwer n. Front Pharmacol. 2022 Mar 2;13:838782. doi: 10.3389/fphar.2022.838782. eCollection 2022. Front Pharmacol. 2022. PMID: 35308198 Free PMC article. Review.
30 results